ACHILLION PHARMACEUTICALS INC 4 SEC Filings

Filed On	Filing
30 Jan 2020	Form 4: G1 Execution SERVICES, Llc, 10% owner and 2 others Disposed of 14,126,415 shares (Other Transaction) ($89M)
29 Jan 2020	Form 4: Vitullo Nicole, Director Returned 3,454,972 shares to the issuer ($21.8M) · Disposed of 272,000 Stock Option (Right to Buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Zelenkofske Steven, EVP, Chief Medical Officer Disposed of 700,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Verwiel Frank, Director Disposed of 132,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Van Nostrand Robert L, Director Returned 40,000 shares to the issuer ($252K) · Disposed of 227,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Truitt Joseph, Director Returned 3,500 shares to the issuer ($22.1K) · Disposed of 2,892,766 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Scheer David, Director Returned 92,764 shares to the issuer ($584K) · Disposed of 227,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Manning Martha E, General Counsel Returned 2,500 shares to the issuer ($15.8K) · Disposed of 365,000 Stock Options (Right to buy) (Disposition to Issuer) · Disposed of 245,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Kishbauch Michael D, Director Disposed of 163,250 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Graves Kurt, Director Returned 22,709 shares to the issuer ($143K) · Disposed of 292,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Gibney Anthony S, EVP, Chief Business Officer Disposed of 700,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Fisherman Jason S, Director Returned 91,500 shares to the issuer ($576K) · Disposed of 227,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Firuta Paul E, EVP, Chief Commercial Officer Disposed of 600,000 Stock Options (Right to buy) (Disposition to Issuer)
29 Jan 2020	Form 4: Di Donato Brian, SVP, Chief Financial Officer Disposed of 700,000 Stock Options (Right to buy) (Disposition to Issuer)
19 Dec 2019	Form 4: Van Nostrand Robert L, Director Received 20,000 shares by exercise or conversion ($65.6K)
14 Nov 2019	Form 4: Fisherman Jason S, Director Received 20,000 shares by exercise or conversion ($65.6K)
14 Nov 2019	Form 4: Scheer David, Director Received 20,000 shares by exercise or conversion ($65.6K) · Sold 10,485 shares ($66.2K)
18 Oct 2019	Form 4: Truitt Joseph, Director Received 133,484 shares by exercise or conversion ($420K) · Sold 133,484 shares ($851K)
11 Feb 2019	Form 4: Di Donato Brian, Chief Financial Officer Granted 500,000 Stock Option (Right to buy)
25 Jan 2019	Form 4: Verwiel Frank, Director Granted 42,000 Stock Option (Right to buy)

Comments